What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials.
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureBridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practiceDepression and sickness behavior are Janus-faced responses to shared inflammatory pathways.ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review.Prevalence of treatment-resistant depression in primary care: cross-sectional data.Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010.Deep brain stimulation for treatment-resistant depression.Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial.Improvement in quality of life in depressed patients following verum acupuncture or electroacupuncture plus paroxetine: A randomized controlled study of 157 cases.Biologically based treatment approaches to the patient with resistant perinatal depression.Advances in the Management of Treatment-Resistant DepressionA randomized controlled trial of Mindfulness-Based Cognitive Therapy (MBCT) versus treatment-as-usual (TAU) for chronic, treatment-resistant depression: study protocol.Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trialHealth-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.Mechanisms of antidepressant resistancePersonality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder.Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants.A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study.Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.Clinical trial design in non-invasive brain stimulation psychiatric research.Approaches to understanding and addressing treatment-resistant depression: a scoping reviewA systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression.Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis.The integrative management of treatment-resistant depression: a comprehensive review and perspectives.Nonremission and time to remission among remitters in major depressive disorder: Revisiting STAR*D.Contrasting patterns of deficits in visuospatial memory and executive function in patients with major depression with and without ECT referral.A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression.Deep brain stimulation in the bed nucleus of the stria terminalis and medial forebrain bundle in a patient with major depressive disorder and anorexia nervosa.Treatment resistant depression in primary care: co-constructing difficult encounters.Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.The economic cost of treatment-resistant depression in patients referred to a specialist service.Ultra-high-frequency left prefrontal transcranial magnetic stimulation as augmentation in severely ill patients with depression: a naturalistic sham-controlled, double-blind, randomized trial.Facilitative effects of VNS on the motor threshold: implications for its antidepressive mode of action?Standardisation framework for the Maudsley staging method for treatment resistance in depression.[Does Prefrontal Noninvasive Brain Stimulation Alleviating Symptoms in Depression and Schizophrenia Impact Mood and Emotion Processing?].Predictive modeling of treatment resistant depression using data from STAR*D and an independent clinical study.
P2860
Q26796436-B1785969-04EA-4187-BD09-4543DFE419F4Q26800235-A52D8922-3A7D-4612-8451-C8F32715B8D2Q26823313-1338A5FA-2010-436A-9A9B-2AC724CB589CQ30470391-422FC0D8-43C7-4289-AC3D-3A58B5C0F57AQ30718433-4FF06799-DEC2-43B7-8515-9AA5EA013D22Q30893498-B0C764BA-6ECF-4089-96A9-EB4B0DFE6D52Q34153354-CDAC974E-7CBA-43B7-BE85-F8D27A3EC31CQ34333771-8B6EE7A6-00C6-454A-A541-C7797EFD72ACQ34397198-92311026-CC07-458E-A7D5-28254705A673Q34798697-ADE2D22C-AEC7-4BF7-88EF-F7B456812B52Q34799159-D373D3FA-F168-47F2-A283-AC99669A7917Q35580600-4D436B47-1EDC-4E6B-931F-41D2CB2F45AEQ35836688-778ECC36-A0D1-417E-9449-38A9D61D5251Q35884803-9914CC28-8276-4A46-8DD3-E4ED4F497404Q36208461-7D7BC3ED-BAB7-48BA-81B1-3DA8E7D64C91Q37091883-8E2C59CA-2D4A-48E9-B81A-7D04715ED30FQ37252495-738BE4D8-D5CD-4DD2-A46A-3DEE557C452EQ37334088-7CEF6D88-6FD8-4D10-AE73-2602C53143CCQ37337969-1FACFA66-6FDE-4220-AFFD-48C99BBF0E00Q37363644-1F21163F-DF6B-40C2-95E2-51F315374DA7Q37639101-14142653-A331-4A88-A881-9D4A98601A8CQ37714491-29227C42-3B65-44D7-A180-971554BAE24AQ37737291-0A3BD374-0BC7-43B0-B375-2EC5658C9FF1Q37871523-05325A0F-6AC4-4217-B2A9-48C926401D4AQ38008653-A031A82D-5F6D-41E2-9A61-CA422C6EC934Q38064097-21AA50A4-65C9-4D58-BFA1-3C2EAA1D14FEQ38154837-83C07A3D-D50F-422A-B86E-C5DE8F5014E4Q38181363-E3024347-93B6-426C-94DE-D547A557A9EAQ38611868-E73FDB44-A9C6-4059-8A74-C1E32B89620EQ39206756-41901C11-1CEE-4F64-99B3-242F639F1167Q41439528-0F04F2C6-BD53-42FD-B139-66A743C175D1Q41838122-7328E03A-915B-4DA1-92BB-411A8D081FA9Q43463416-9E922E50-153F-461D-826A-AC1C04ED711BQ45942875-56353C38-2A85-456D-B646-E49D15619D85Q47570085-773F2271-92F7-495B-8B11-351E47E3B960Q48389043-2E560E8E-D2B6-4403-9840-142C629976A3Q48465880-96A8241A-4985-44F1-959D-55151556C515Q53696344-659CE63F-A2A2-40A4-AF6F-F54FEF1B1420Q53772076-0800A7AA-3744-41E4-AED1-BCC3E9688716Q55343118-9377EE1E-F31F-4D70-8E12-1C456BBFC5B7
P2860
What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
What is the meaning of treatme ...... of current randomized trials.
@ast
What is the meaning of treatme ...... of current randomized trials.
@en
type
label
What is the meaning of treatme ...... of current randomized trials.
@ast
What is the meaning of treatme ...... of current randomized trials.
@en
prefLabel
What is the meaning of treatme ...... of current randomized trials.
@ast
What is the meaning of treatme ...... of current randomized trials.
@en
P1476
What is the meaning of treatme ...... of current randomized trials.
@en
P2093
Marcelo T Berlim
P304
P356
10.1016/J.EURONEURO.2007.03.009
P407
P577
2007-05-23T00:00:00Z